TNF and neoplasm: As a result, administering the delivery system combined with plasmid DNA encoding tumor necrosis factor alpha (TNFα) resulted in rapid and sustained tumor regression for 40 days, during which all A431 tumor-bearing mice survived (90% of which had a complete response) and were well-tolerated.